← Back to directory

Antônio C. Buzaid

Researcher Next ID · RN-029759

Researcher · Medicine

Beneficência Portuguesa de São Paulo

São Paulo, Chile

Not currently recruitingFunding unknown
Works count
211
Citation count
14,233
H-index
44
i10-index
104

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Cutaneous Melanoma Detection and Management
Melanoma and MAPK Pathways
Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Cancer Treatment and Pharmacology

Publications

  • Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors

    Journal of Immunotherapy · 2016 · 10.1097/cji.0000000000000141

  • Staging of cutaneous melanoma

    Annals of Oncology · 2009 · 10.1093/annonc/mdp256

  • Final Version of 2009 AJCC Melanoma Staging and Classification

    Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.4799

  • An Evidence-based Staging System for Cutaneous Melanoma

    CA A Cancer Journal for Clinicians · 2004 · 10.3322/canjclin.54.3.131

  • Dendritic cell?tumor cell hybrid vaccination for metastatic cancer

    Cancer Immunology Immunotherapy · 2004 · 10.1007/s00262-004-0551-7

  • Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

    Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.11.044

  • New TNM melanoma staging system: Linking biology and natural history to clinical outcomes

    Seminars in Surgical Oncology · 2003 · 10.1002/ssu.10020

  • Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients

    Cancer Chemotherapy and Pharmacology · 2002 · 10.1007/s00280-002-0437-3

  • Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

    Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.07.044

  • The New Melanoma Staging System

    Cancer Control · 2002 · 10.1177/107327480200900102

  • Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

    Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.16.3635

  • A new American Joint Committee on Cancer staging system for cutaneous melanoma

    Cancer · 2000 · 10.1002/(sici)1097-0142(20000315)88:6<1484::aid-cncr29>3.0.co;2-d

  • Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.

    PubMed · 2000

  • Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma

    Cancer · 1999 · 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q

  • Prognostic factors for survival of patients treated systemically for disseminated melanoma.

    Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.3.1103

  • Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

    Journal of Clinical Oncology · 1998 · 10.1200/jco.1998.16.5.1752

  • Minocycline and Ethylenediaminetetraacetate for the Prevention of Recurrent Vascular Catheter Infections

    Clinical Infectious Diseases · 1997 · 10.1086/514518

  • Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

    Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.3.1039

  • Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.

    Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.8.2826

  • Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-α

    Annals of Oncology · 1996 · 10.1093/oxfordjournals.annonc.a010762

  • Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.

    Journal of Clinical Oncology · 1995 · 10.1200/jco.1995.13.9.2361

  • Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.

    Journal of Clinical Oncology · 1995 · 10.1200/jco.1995.13.12.2895

  • Role of computed tomography in the staging of patients with local-regional metastases of melanoma.

    Journal of Clinical Oncology · 1995 · 10.1200/jco.1995.13.8.2104

  • Role of computed tomography in the staging of primary melanoma.

    Journal of Clinical Oncology · 1993 · 10.1200/jco.1993.11.4.638

  • Management of refractory myeloma: a review.

    Journal of Clinical Oncology · 1988 · 10.1200/jco.1988.6.5.889

Current projects

    No projects listed.